Aller au contenu principal
Profil bibliographique

Drew Hotson

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

3Publications signalées
14Citations signalées
1Affiliations récentes

Les institutions déclarées

Les domaines associés

Cancer Immunotherapy and BiomarkersCAR-T cell therapy researchMelanoma and MAPK PathwaysImmune Cell Function and InteractionChronic Lymphocytic Leukemia Research

Les publications récentes

Accès ouvert 2014 conference-abstract OpenAlex

Systems biology analysis of immune signaling in peripheral blood mononuclear cells (PBMC) of melanoma patients receiving ipilimumab; basis for response biomarker identification

Drew Hotson, Ryan Alvarado, Andy Conroy, Santosh Putta et autres

Ipilimumab, an anti-CTLA-4 monoclonal antibody, is approved for treatment of unresectable/metastatic melanoma [ 1 ]. Treatment benefits only a subset of patients (pts) and is associated with significant adverse effects. Biomarkers of pt response are needed. Single cell network profiling (SCNP) is …

us, it (code pays fourni par la source)

12 citations Journal of Translational Medicine
Accès ouvert 2013 conference-abstract OpenAlex

Systems biology analysis of immune signaling in peripheral blood mononuclear cells (PBMC) of melanoma patients receiving ipilimumab; basis for clinical response biomarker identification

Drew Hotson, Ryan Alvarado, Andrew Conroy, Santosh Putta et autres

Meeting abstracts Ipilimumab, an anti-CTLA-4 monoclonal antibody, is approved for treatment of unresectable/metastatic melanoma. Treatment benefits only a subset of patients (pts) and is associated with significant adverse effects. Biomarkers of pt response are needed. Single cell network profiling

us, it (code pays fourni par la source)

1 citation Journal for ImmunoTherapy of Cancer

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.